Collegium Pharmaceutical Ratios (2014-2026) | COLL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	60.57%	58.49%	-3.48%	57.90%	42.38%	46.33%	35.40%	53.47%	54.47%	58.75%	63.19%	63.11%	62.51%	60.76%	263.94%	54.75%	57.65%	61.70%	62.49%	60.59%
EBT Margin (Quarter)	13.25%	11.46%	-101.43%	-18.92%	-5.38%	1.13%	-5.54%	-12.13%	13.13%	21.05%	31.19%	25.27%	20.03%	9.78%	46.37%	1.76%	9.06%	20.75%	14.13%	9.68%
EBIT Margin (Quarter)	19.78%	17.95%	-89.02%	-11.96%	8.99%	16.11%	8.36%	17.01%	26.29%	32.93%	41.20%	34.14%	32.68%	21.87%	102.34%	12.20%	18.67%	29.66%	29.57%	15.97%
EBITDA Margin (Quarter)	19.78%	17.95%	-89.02%	-11.96%	8.99%	16.11%	8.36%	17.01%	26.29%	32.93%	41.20%	34.14%	32.68%	21.87%	102.34%	12.20%	18.67%	29.66%	29.57%	15.97%
Operating Margin (Quarter)	19.78%	17.95%	-89.02%	-11.96%	8.99%	16.11%	8.36%	17.01%	26.29%	32.93%	41.20%	34.14%	32.68%	21.87%	102.34%	12.20%	18.67%	29.66%	29.57%	15.97%
Net Margin (Quarter)	89.23%	10.21%	-65.31%	-15.60%	-4.20%	0.36%	-5.12%	-12.04%	9.60%	15.09%	21.33%	19.12%	13.50%	5.86%	33.66%	1.36%	6.37%	15.05%	8.26%	7.49%
FCF Margin (Quarter)	34.74%	21.53%	93.10%	-30.36%	32.37%	33.58%	46.49%	18.99%	73.53%	54.10%	48.87%	42.35%	46.65%	-6.20%	229.71%	30.72%	38.50%	37.38%	60.25%	29.41%
Efficiency
Inventory Average (Quarter)	17.55M	18.48M	17.38M	48.77M	78.96M	71.21M	55.58M	39.70M	29.46M	30.08M	33.23M	31.80M	29.57M	32.95M	36.80M	36.39M	37.68M	38.10M	39.48M	41.83M
Assets Average (Quarter)	679.90M	727.77M	716.94M	969.11M	1,245.86M	1,223.26M	1,187.54M	1,194.21M	1,214.11M	1,195.74M	1,160.44M	1,128.78M	1,083.82M	1,344.27M	1,649.37M	1,647.49M	1,612.01M	1,599.98M	1,632.08M	1,654.39M
Invested Capital (Quarter)	143.75M	143.75M	143.75M	143.75M	143.75M	600.00M	575.00M	241.50M	26.35M	183.33M	183.33M	183.33M	183.33M	64.58M	64.58M	24.57M	64.58M	0.02M	29.00M	32.62M
Asset Utilization Ratio (Quarter)	0.48	0.45	0.40	0.29	0.26	0.30	0.40	0.45	0.45	0.47	0.49	0.50	0.53	0.45	0.30	0.32	0.35	0.38	0.48	0.48
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.91	1.68	-7.17	-0.12	0.13	0.25	0.57	1.15	1.63	2.17	3.20	2.83	3.05	0.38	1.68	0.24	0.39	0.68	3.15	0.34
Debt Ratio (Quarter)	0.19	0.16	0.16	0.50	0.49	0.49	0.48	0.44	0.41	0.38	0.35	0.32	0.30	0.39	0.37	0.34	0.37	0.31	0.34	0.34
Times Interest Earned (Quarter)	0.91	1.68	-7.17	-0.12	0.13	0.25	0.57	1.15	1.63	2.17	3.20	2.83	3.05	0.38	1.68	0.24	0.39	0.68	3.15	0.34
Valuation
Enterprise Value (Quarter)	-202.77M	-193.24M	-186.43M	-106.70M	-122.72M	-134.13M	-173.69M	-269.48M	-325.47M	-304.56M	-310.55M	-318.05M	-271.63M	-119.96M	-162.76M	-197.77M	-137.20M	-285.86M	-251.10M	-288.50M
Return Ratios
Return on Sales (Quarter)	0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	15.94%	14.55%	4.03%	-2.28%	-2.27%	-1.55%	4.42%	8.70%	11.87%	16.01%	23.77%	28.11%	32.74%	21.87%	14.90%	12.24%	11.31%	13.69%	15.07%	15.49%
Return on Invested Capital (Quarter)	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Collegium Pharmaceutical Ratios (2014-2026) | COLL

Research Tools

Developers

Collegium Pharmaceutical Ratios (2014-2026) | COLL

Create an account

Sign In

Reset Password